No increased death toll for long-term MHT

Author(s)

• Amos Pines
  Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Citations

1. Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality. The Women’s Health Initiative randomized trials. JAMA 2017;318:927-38
   http://www.ncbi.nlm.nih.gov/pubmed/28898378
2. Crandall CJ, Hovey KM, Andrews C, et al. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women’s Health Initiative Observational Study. Menopause 2017 Jul 10. Epub ahead of print
   http://www.ncbi.nlm.nih.gov/pubmed/28697036
3. Crandall CJ, Hovey KM, Andrews CA, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women’s Health Initiative Observational Study. Menopause 2017 Aug 14. Epub ahead of print
   http://www.ncbi.nlm.nih.gov/pubmed/28816933
4. Simin J, Tamimi R, Lagergren J, Adami HO, Brusselaers N. Menopausal hormone therapy and cancer risk: an overestimated risk? Eur J Cancer 2017;84:60-8
   http://www.ncbi.nlm.nih.gov/pubmed/28783542